CompaniesByCap
GTBP
GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare

GT Biopharma, Inc. Income Statement 2010–2020

Income StatementBalance SheetCash Flow
Dec 2020Dec 2019Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010
Revenues
Revenue000027,00061,000368,000342,00026,00011,000
Gross Profit0027,0004,000142,000248,000-22,000-54,000
Profitability
Operating Income-6.8M16.1M-135.6M-9.4M-8.9M-2.4M-793,000-3.5M-3.9M-2.5M
EBITDA
Net Income-28.3M-38.6M-144.2M9.8M-21.5M-23.5M-501,000-5.2M-3.7M-3.0M
Per Share Data
EPS (diluted)$-8.60$119.91$-8.96
Shares Outstanding (dil.)4M3M0M0M2M2M573M501M269M150M

GT Biopharma, Inc. Income Statement — FAQ

GT Biopharma, Inc. (GTBP) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see GTBP's income statement history?

The chart and table above show GT Biopharma, Inc.'s income statement by year and by quarter, including the growth rate.